Genome-wide CRISPR screens reveal synthetic lethal interaction between CREBBP and EP300 in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common type of aggressive lymphoid malignancy and a highly heterogeneous disease. In this study, we performed whole-genome and transcriptome sequencing, and a genome-wide CRISPR-Cas9-knockout screen to study an activated B-cell-like DLBCL cell line (...

Descripción completa

Detalles Bibliográficos
Autores principales: Nie, Man, Du, Likun, Ren, Weicheng, Joung, Julia, Ye, Xiaofei, Shi, Xi, Ciftci, Sibel, Liu, Dongbing, Wu, Kui, Zhang, Feng, Pan-Hammarström, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080727/
https://www.ncbi.nlm.nih.gov/pubmed/33911074
http://dx.doi.org/10.1038/s41419-021-03695-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080727/
https://www.ncbi.nlm.nih.gov/pubmed/33911074
http://dx.doi.org/10.1038/s41419-021-03695-8

Ejemplares similares